[Results and experiences in the immunosuppressive therapy of rheumatoid arthritis].
An analysis of the results of treatment-in five different hospitals and with such immunosuppressants as cyclophosphamide, azathioprine, and trenimone - of 550 patients with rheumatoid arthritis showed an overall rate of improvement of 36%. Cyclophosphamide, because of the relatively small number of side effects and the excellent therapeutical results obtained, proved to be much better than the other two immunosuppressive agents. Also, because the dosage required is comparatively low, patients over procreative age could be included in the program of treatment with immunosuppressants.
D000328:Adult; D001172:Arthritis, Rheumatoid / Q000188:drug therapy*; D001379:Azathioprine / Q000627:therapeutic use; D003520:Cyclophosphamide / Q000627:therapeutic use; D006801:Humans; D007165:Immunosuppression Therapy; D008875:Middle Aged; D014228:Triaziquone / Q000627:therapeutic use
D003520:Cyclophosphamide; D014228:Triaziquone; D001379:Azathioprine
Ergebnisse und Erfahrungen zur immunsuppressiven Therapie der Rheumatoiden Arthritis